Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment

Cohen,Zoya; Maimon,Yair; Yoeli-Lerner,Merav; Yang,Peiying; Samuels,Noah; Berger,Raanan

doi:10.3892/ijo.2014.2711

Selective anticancer effects and protection from chemotherapy by the botanical compound LCS101: Implications for cancer treatment

Authors:
- Zoya Cohen
- Yair Maimon
- Merav Yoeli-Lerner
- Peiying Yang
- Noah Samuels
- Raanan Berger
View Affiliations

Affiliations: Tal Center for Integrative Medicine, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel, Department of General Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA, Institute of Oncology, Sheba Medical Center, Tel Hashomer, Israel
Published online on: October 17, 2014 https://doi.org/10.3892/ijo.2014.2711
Pages: 308-316

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

There is a need for new options for reducing the side effects of cancer treatment, without compromising efficacy, enabling patients to complete treatment regimens. The botanical compound LCS101 exhibits inhibitory effects on cancer cell growth, and reduces chemotherapy-induced hematological toxicities. The aim of the present study is to examine the selectivity of the effects of the compound, alone and in conjunction with conventional chemotherapy agents, on cancer cell proliferation. The effects of LCS101 were tested on a number of cancer cell lines (breast, MCF7, MDA-MB‑231; colorectal, HCT116; prostate, PC-3, DU-145) and on non-tumorigenic normal human epithelial cells (breast, MCF10A; prostate, EP#2). Cell viability was analyzed using an XTT assay and observed by light microscopy. Necrosis and apoptosis were examined using FACS analysis and immunoblotting. LCS101 selectively induced cell death in breast, colon and prostate cancer cell lines, as measured by XTT assay. Light microscopy and FACS analysis showed changes indicative of a necrotic process. LCS101 was also found to induce PARP-1 reduction in breast cancer cells, with no effect on non-tumorigenic breast epithelial cells. While LCS101 increased cell death in cancer cells exposed to doxorubicin and 5-FU, it showed a protective effect on non-tumorigenic human epithelial cells from chemotherapy-induced cell death. A similar selective effect was observed with apoptosis-associated PARP-1 cleavage. The findings demonstrate that the anti-proliferative effects exhibited by the botanical compound LCS101 are selective to cancer cells, and offer protection to non-tumorigenic normal epithelial cells from chemotherapy agents.

View Figures

View References

1	World Health Organization fact sheet No. 297. http://www.who.int/mediacentre/factsheets/fs297/en/index.html:. Accessed December 28, 2013
2	Liu SH and Cheng YC: Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 140:614–623. 2012. View Article : Google Scholar : PubMed/NCBI
3	Samuels N, Maimon Y and Zisk-Rony RY: Effect of the botanical compound LCS101 on chemotherapy-induced symptoms in patients with breast cancer: a case series report. Integr Med Insights. 8:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
4	Maimon Y, Karaush V, Yaal-Hahoshen N, Ben-Yosef R, Ron I, Vexler A and Lev-Ari S: Effect of Chinese herbal therapy on breast cancer adenocarcinoma cell lines. J Int Med Res. 38:2033–2039. 2010. View Article : Google Scholar : PubMed/NCBI
5	Rachmut IH, Samuels N, Melnick SJ, Ramachandran C, Sharabi Y, Pavlovsky A, Maimon Y and Shoham J: Immunomodulatory effects of the botanical compound LCS101: implications for cancer treatment. Onco Targets Ther. 6:437–445. 2013.PubMed/NCBI
6	Yaal-Hahoshen N, Maimon Y, Siegelmann-Danieli N, Lev-Ari S, Ron IG, Sperber F, Samuels N, Shoham J and Merimsky O: A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer. Oncologist. 16:1197–1202. 2011. View Article : Google Scholar
7	Leshem O, Madar S, Kogan-Sakin I, Kamer I, Goldstein I, Brosh R, Cohen Y, Jacob-Hirsch J, Ehrlich M, Ben-Sasson S, Goldfinger N, Loewenthal R, Gazit E, Rotter V and Berger R: TMPRSS2/ERG promotes epithelial to mesenchymal transition through the ZEB1/ZEB2 axis in a prostate cancer model. PLoS One. 6:e216502011. View Article : Google Scholar : PubMed/NCBI
8	Butters DJ, Ghersi D, Wilcken N, Kirk SJ and Mallon PT: Addition of drug/s to a chemotherapy regimen for metastatic breast cancer. Cochrane Database Syst Rev. 2010.CD003368 View Article : Google Scholar
9	Sun JY, Yang H, Miao S, Li JP, Wang SW, Zhu MZ, Xie YH, Wang JB, Liu Z and Yang Q: Suppressive effects of swainsonine on C6 glioma cell in vitro and in vivo. Phytomedicine. 16:1070–1074. 2009. View Article : Google Scholar : PubMed/NCBI
10	Huang HL, Chen CC, Yeh CY and Huang RL: Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol. 97:21–29. 2005. View Article : Google Scholar : PubMed/NCBI
11	Kang SA, Park HJ, Kim MJ, Lee SY, Han SW and Leem KH: Citri Reticulatae Viride Pericarpium extract induced apoptosis in SNU-C4, human colon cancer cells. J Ethnopharmacol. 97:231–235. 2005. View Article : Google Scholar
12	Kim MJ, Park HJ, Hong MS, Park HJ, Kim MS, Leem KH, Kim JB, Kim YJ and Kim HK: Citrus Reticulata blanco induces apoptosis in human gastric cancer cells SNU-668. Nutr Cancer. 51:78–82. 2005. View Article : Google Scholar : PubMed/NCBI
13	Jeong JC, Kim JW, Kwon CH, Kim TH and Kim YK: Fructus ligustri lucidi extracts induce human glioma cell death through regulation of Akt/mTOR pathway in vitro and reduce glioma tumor growth in U87MG xenograft mouse model. Phytother Res. 25:429–434. 2011. View Article : Google Scholar
14	Wong BY, Lau BH, Jia TY and Wan CP: Oldenlandia diffusa and Scutellaria barbata augment macrophage oxidative burst and inhibit tumor growth. Cancer Biother Radiopharm. 11:51–56. 1996. View Article : Google Scholar : PubMed/NCBI
15	Gupta S, Zhang D, Yi J and Shao J: Anticancer activities of Oldenlandia diffusa. J Herb Pharmacother. 4:21–33. 2004. View Article : Google Scholar
16	Ou TT, Wu CH, Hsu JD, Chyau CC, Lee HJ and Wang CJ: Paeonia lactiflora Pall inhibits bladder cancer growth involving phosphorylation of Chk2 in vitro and in vivo. J Ethnopharmacol. 135:162–172. 2011. View Article : Google Scholar
17	Feng L, Jia X, Zhu M, Chen Y and Shi F: Chemoprevention by Prunella vulgaris L. extract of non-small cell lung cancer via promoting apoptosis and regulating the cell cycle. Asian Pac J Cancer Prev. 11:1355–1358. 2010.
18	Choi JH, Han EH, Hwang YP, Choi JM, Choi CY, Chung YC, Seo JK and Jeong HG: Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem Toxicol. 48:564–571. 2010. View Article : Google Scholar : PubMed/NCBI
19	Klawitter J, Klawitter J, Gurshtein J, Corby K, Fong S, Tagliaferri M, Quattrochi L, Cohen I, Shtivelman E and Christians U: Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study. Int J Cancer. 129:2945–2957. 2011. View Article : Google Scholar
20	Fong S, Shoemaker M, Cadaoas J, Lo A, Liao W, Tagliaferri M, Cohen I and Shtivelman E: Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells. Cancer Biol Ther. 7:577–586. 2008. View Article : Google Scholar
21	Wong BY, Nguyen DL, Lin T, Wong HH, Cavalcante A, Greenberg NM, Hausted RP and Zheng J: Chinese medicinal herb Scutellaria barbata modulates apoptosis and cell survival in murine and human prostate cancer cells and tumor development in TRAMP mice. Eur J Cancer Prev. 18:331–341. 2009. View Article : Google Scholar : PubMed/NCBI